Skip to main content

Table 5 Change in mean blood pressure, lipid levels, and fasting glucose measures for participants who had abnormal levels at baseline

From: A real-world evaluation of a tertiary care childhood obesity intervention to reduce metabolic risk in a hard-to-reach urban population

Measure Baseline Mean ± SD Follow-up Mean ± SD Difference (Δ) Mean (95% CI) p value*
SBP (mm Hg) 122.6 ± 7.6 117.3 ± 11.3 −15.3(− 7.7, − 2.9) p < 0.0001
DBP (mm Hg) 77.1 ± 7.7 67.6 ± 10.7 −9.6 (− 13.5, − 5.6) p < 0.0001
TC (mg/dL) 196.0 ± 25.4 192.3 ± 32.0 −3.7 (− 9.8, 2.3) p = 0.221
HDL (mg/dL) 36.2 ± 4.6 40.6 ± 8.8 4.4 (2.0, 6.8) p < 0.001
LDL (mg/dL) 134.5 ± 19.4 126.7 ± 29.2 − 7.8 (− 15.1, − 0.55) p = 0.036
TG (mg/dL) 140.8 ± 58.3 122.0 ± 49.2 −18.9 (− 41.8, 4.0) p = 0.103
Glucose (mg/dL) 120.7 ± 27.4 91.7 ± 7.7 −29.0 (− 3.9, 0.99) p = 0.054
  1. * p-values refer to paired-sample t-tests